ICAR MED REC 0032 2019
Managing Moderate and Severe Pain in Mountain Rescue
No. | ICAR-MED-REC-0032-2019 |
Version | 2.1 |
Title | Managing Moderate and Severe Pain in Mountain Rescue |
Author(s) | Ellerton, John |
Responsible person | Ellerton, John |
Originally based on | Managing Moderate and Severe Pain in Mountain Rescue |
Date of publication | 12/10/2019 |
Valid Until | 11/10/2024 |
Background
The original paper was reviewed and Medline literature searches using keywords 'analgesia' and 'EMS' / 'prehospital', 'mountain rescue' were carried out to identify relevant new references. Addistional references were added by the ICAR MedCom recview panel. An ACCP redommendation grade was allocated to the recommendations.
Download(s)
 | ICAR MED REC 0032 2019 Management of Moderate and Severe Pain in Mountain Rescue MED REC 0032 2019 Management of Pain in MR.pdf (1.08MB) |
| MED REC 0032 2019 Management of Pain in MR.pdf (1.08MB) |
Further Reading
A recent study by Dr Blancher et al from Grenoble (FR) has compared the intranasal use of sufentanil versus the intravenous use of morphine for acute severe trauma pain. The aim was to determine whether IN sufentanil (INS) for patients presenting to an emergency department with acute severe traumatic pain results in a reduction in pain intensity non-inferior to IVM.
This study confirmed the non-inferiority of INS compared to IVM for pain reduction at 30 minutes after administration in patients with severe traumatic pain presenting to an emergency department. The IN route, with no need to obtain a venous route, may allow early and effective analgesia in emergency settings and in difficult situations. Confirmation of the safety profile of INS will require further larger studies.
Citation: Blancher M, Maignan M, Clape´ C, Quesada J-L, Collomb-Muret R, Albasini F, et al. (2019) Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A doubleblind randomized non-inferiority study. PLoS Med 16(7): e1002849.